Full Text View
Tabular View
No Study Results Posted
Related Studies
Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis (CobAcE)
This study is not yet open for participant recruitment.
Study NCT00707070   Information provided by Universita di Verona
First Received: June 26, 2008   Last Updated: June 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Plaque Psoriasis
Additional conditions recognized in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
efalizumab plus placebo
efalizumab plus acitretin
Additional drug interventions recognized in this trial
Acitretin
More general drug interventions related to this trial
Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Universita di Verona


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services